Despite egg-adaptive mutations, the 2012-13 H3N2 influenza vaccine induced comparable antibody titers to the intended strain (original) (raw)
Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013
Ilan Youngster
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018
View PDFchevron_right
Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses
Mel Krajden
PLoS ONE, 2014
View PDFchevron_right
Influenza A/Subtype and B/Lineage Effectiveness Estimates for the 2011-2012 Trivalent Vaccine: Cross-Season and Cross-Lineage Protection With Unchanged Vaccine
Jonathan Gubbay
Journal of Infectious Diseases, 2014
View PDFchevron_right
Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015
Mary Nowalk
The Journal of infectious diseases, 2016
View PDFchevron_right
A perfect storm: Impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014-15 season
James Dickinson
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016
View PDFchevron_right
M2-Deficient Single-Replication Influenza Vaccine–Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain
Pamuk Bilsel
The Journal of Infectious Diseases, 2021
View PDFchevron_right
H3N2 Mismatch of 2014-15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps
Courtney Finch, H. Xie
Scientific reports, 2015
View PDFchevron_right
Single Replication M2SR Influenza Vaccine Induced Immune Responses Associated with Protection Against Human Challenge with Highly Drifted H3N2 Influenza Strain
Renee Herber
2021
View PDFchevron_right
Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites
Aimin Li
Influenza and Other Respiratory Viruses, 2013
View PDFchevron_right
Adjuvanted Influenza Vaccines Elicits Higher Antibody Responses against the A(H3N2) Subtype than Non-Adjuvanted Vaccines
Laura Sánchez de Prada
Vaccines
View PDFchevron_right
WHO recommendations for the viruses used in the 2013–2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013
Gary S Grohmann
Vaccine, 2014
View PDFchevron_right
Title: Population effect of influenza vaccination under co-circulation of non-vaccine variants and the case for a bivalent A/H3N2 vaccine component
Edward Goldstein
View PDFchevron_right
Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018–2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin
Maryna Eichelberger
Clinical Infectious Diseases, 2020
View PDFchevron_right
Genetic and Antigenic Typing of Seasonal Influenza Virus Breakthrough Cases from a 2008-2009 Vaccine Efficacy Trial
Jirí Beran, Janet McElhaney
Clinical and Vaccine Immunology, 2014
View PDFchevron_right
Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018
priyam sharma
Scientific Reports, 2019
View PDFchevron_right
Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies - United States
Amanda Balish
MMWR. Morbidity and mortality weekly report, 2012
View PDFchevron_right
Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses
H Rogier van Doorn
Viruses, 2022
View PDFchevron_right
Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes—Systematic Literature Review and Expert Consensus
radek wojcik
Vaccines, 2021
View PDFchevron_right
Pre-existing immunity to influenza viruses through infection and/or vaccination leads to viral mutational signatures associated with unique immune responses during a subsequent infection
Alaa Selim
View PDFchevron_right
Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002–2003 to 2017–2018
Raúl O. de Lejarazu
International Journal of Environmental Research and Public Health, 2020
View PDFchevron_right
WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011
Gary S Grohmann
Vaccine, 2012
View PDFchevron_right
Integrated sentinel surveillance linking genetic, antigenic and epidemiologic monitoring of influenza vaccine-virus relatedness and effectiveness, 2013-14 season
James Dickinson
The Journal of infectious diseases, 2015
View PDFchevron_right
Vaccination against influenza: Role and limitations in pandemic intervention plans
Terri Rebmann
View PDFchevron_right
Single PA mutation as a high yield determinant of avian influenza vaccines
Kisoon Kim
Scientific Reports, 2017
View PDFchevron_right
Eliciting broadly protective antibody responses against influenza
Ted Ross
Current Opinion in Immunology, 2014
View PDFchevron_right
Vaccinia-based influenza vaccine overcomes previously induced immunodominance hierarchy for heterosubtypic protection
sunje woo
European Journal of Immunology, 2014
View PDFchevron_right